These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

727 related items for PubMed ID: 1335058

  • 1. Stimulation of beta adrenoceptors in a human monocyte cell line (U937) up-regulates cyclic AMP-specific phosphodiesterase activity.
    Torphy TJ, Zhou HL, Cieslinski LB.
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1195-205. PubMed ID: 1335058
    [Abstract] [Full Text] [Related]

  • 2. Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-alpha generation from human peripheral blood monocytes.
    Seldon PM, Barnes PJ, Giembycz MA.
    Cell Biochem Biophys; 1998 Dec; 29(1-2):179-201. PubMed ID: 9631245
    [Abstract] [Full Text] [Related]

  • 3. Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle.
    Torphy TJ, Cieslinski LB.
    Mol Pharmacol; 1990 Feb; 37(2):206-14. PubMed ID: 2154670
    [Abstract] [Full Text] [Related]

  • 4. Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase.
    Seldon PM, Barnes PJ, Meja K, Giembycz MA.
    Mol Pharmacol; 1995 Oct; 48(4):747-57. PubMed ID: 7476903
    [Abstract] [Full Text] [Related]

  • 5. Prolonged beta adrenoceptor stimulation up-regulates cAMP phosphodiesterase activity in human monocytes by increasing mRNA and protein for phosphodiesterases 4A and 4B.
    Manning CD, McLaughlin MM, Livi GP, Cieslinski LB, Torphy TJ, Barnette MS.
    J Pharmacol Exp Ther; 1996 Feb; 276(2):810-8. PubMed ID: 8632354
    [Abstract] [Full Text] [Related]

  • 6. Identification, characterization, and functional role of phosphodiesterase type IV in cerebral vessels: effects of selective phosphodiesterase inhibitors.
    Willette RN, Shiloh AO, Sauermelch CF, Sulpizio A, Michell MP, Cieslinski LB, Torphy TJ, Ohlstein EH.
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):210-9. PubMed ID: 9040501
    [Abstract] [Full Text] [Related]

  • 7. Identification, characterization and functional role of phosphodiesterase isozymes in human airway smooth muscle.
    Torphy TJ, Undem BJ, Cieslinski LB, Luttmann MA, Reeves ML, Hay DW.
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1213-23. PubMed ID: 8389856
    [Abstract] [Full Text] [Related]

  • 8. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P, Prigent AF, Lagarde M, Nemoz G.
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [Abstract] [Full Text] [Related]

  • 9. Regulation of distinct cyclic AMP-specific phosphodiesterase (phosphodiesterase type 4) isozymes in human monocytic cells.
    Verghese MW, McConnell RT, Lenhard JM, Hamacher L, Jin SL.
    Mol Pharmacol; 1995 Jun; 47(6):1164-71. PubMed ID: 7603456
    [Abstract] [Full Text] [Related]

  • 10. Potentiation of erectile response and cAMP accumulation by combination of prostaglandin E1 and rolipram, a selective inhibitor of the type 4 phosphodiesterase (PDE 4).
    Bivalacqua TJ, Champion HC, Rajasekaran M, Sikka SC, Kadowitz PJ, Doherty PC, Hellstrom WJ.
    J Urol; 1999 Nov; 162(5):1848-55. PubMed ID: 10524946
    [Abstract] [Full Text] [Related]

  • 11. Distinct profiles of phosphodiesterase isozymes in cultured cells derived from nonpigmented and pigmented ocular ciliary epithelium.
    Bode DC, Hamel LT, Wax MB.
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1286-91. PubMed ID: 8263791
    [Abstract] [Full Text] [Related]

  • 12. Porcine detrusor cyclic nucleotide phosphodiesterase isoenzymes: characterization and functional effects of various phosphodiesterase inhibitors in vitro.
    Truss MC, Uckert S, Stief CG, Schulz-Knappe P, Hess R, Forssmann WG, Jonas U.
    Urology; 1995 May; 45(5):893-901. PubMed ID: 7747383
    [Abstract] [Full Text] [Related]

  • 13. Effect of adrenaline and glucocorticoids on monocyte cAMP-specific phosphodiesterase (PDE4) in a monocytic cell line.
    Delgado M, Fernández-Alfonso MS, Fuentes A.
    Arch Dermatol Res; 2002 Jul; 294(4):190-7. PubMed ID: 12111350
    [Abstract] [Full Text] [Related]

  • 14. Correlation of cell-free brain cyclic nucleotide phosphodiesterase activities to cyclic AMP decay in intact brain slices.
    Whalin ME, Garrett RL, Thompson WJ, Strada SJ.
    Second Messengers Phosphoproteins; 2002 Jul; 12(5-6):311-25. PubMed ID: 2856115
    [Abstract] [Full Text] [Related]

  • 15. Role of cyclic nucleotide phosphodiesterase isozymes in intact canine trachealis.
    Torphy TJ, Zhou HL, Burman M, Huang LB.
    Mol Pharmacol; 1991 Mar; 39(3):376-84. PubMed ID: 1848659
    [Abstract] [Full Text] [Related]

  • 16. Characterization of phosphodiesterase 4 in guinea-pig macrophages: multiple activities, association states and sensitivity to selective inhibitors.
    Kelly JJ, Barnes PJ, Giembycz MA.
    Br J Pharmacol; 1998 May; 124(1):129-40. PubMed ID: 9630352
    [Abstract] [Full Text] [Related]

  • 17. Initial biochemical and functional characterization of cyclic nucleotide phosphodiesterase isozymes in canine colonic smooth muscle.
    Barnette MS, Manning CD, Price WJ, Barone FC.
    J Pharmacol Exp Ther; 1993 Feb; 264(2):801-12. PubMed ID: 7679736
    [Abstract] [Full Text] [Related]

  • 18. Upregulation of cAMP-specific PDE-4 activity following ligation of the TCR complex on thymocytes is blocked by selective inhibitors of protein kinase C and tyrosyl kinases.
    Michie AM, Rena G, Harnett MM, Houslay MD.
    Cell Biochem Biophys; 1998 Feb; 28(2-3):161-85. PubMed ID: 9515165
    [Abstract] [Full Text] [Related]

  • 19. Suppression of human eosinophil respiratory burst and cyclic AMP hydrolysis by inhibitors of type IV phosphodiesterase: interaction with the beta adrenoceptor agonist albuterol.
    Dent G, Giembycz MA, Evans PM, Rabe KF, Barnes PJ.
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1167-74. PubMed ID: 7996422
    [Abstract] [Full Text] [Related]

  • 20. delta-Opioid receptor activates cAMP phosphodiesterase activities in neuroblastoma x glioma NG108-15 hybrid cells.
    Law PY, Loh HH.
    Mol Pharmacol; 1993 May; 43(5):684-93. PubMed ID: 8388986
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.